Latest News

03/01/2010

“WIN A $10,000 EDUCATION FUND FOR YOUR MIRACLE CHILD”

Ferring Pharmaceuticals Announces 2010 My Little Miracle Essay Contest PARSIPPANY, NJ – March...

02/25/2010

“FERRING PHARMACEUTICALS AND GENE SECURITY NETWORK PARTNER TO TEST ADVANCED PREIMPLANTATION GENETIC DIAGNOSIS (PGD) TECHNOLOGY ”

Eleven-Center Trial to Evaluate Technology for Superior Accuracy in IVF Embryo Selection PARSIPPAN...

12/04/2009

“DEGARELIX (FIRMAGON®) VS LEUPROLIDE (LUPRON DEPOT®) IN PATIENTS WITH ADVANCED PROSTATE CANCER: FURTHER ANALYSIS FROM A PHASE III PIVOTAL TRIAL”

Investigators Presented Results at the Society of Urologic Oncology Annual Meeting BETHESDA, MD &nd...

10/20/2009

“RESEARCH COMPARES MENOPUR® WITH rFSH IN GNRH ANTAGONIST IVF CYCLES”

Ferring Pharmaceuticals Presents Study Results at American Society for Reproductive Medicine Annual ...

08/31/2009

“RECENTLY PUBLISHED STUDY DEMONSTRATES PHARMACOKINETIC ADVANTAGES OF ENDOMETRIN® OVER CRINONE® FOR PROGESTERONE SUPPLEMENTATION”

Study Published Online in Fertility & Sterility PARSIPPANY, NJ – August 31, 2009 – ...

Careers Apply I am ferring.. Are you? Search our career opportunities and find out.

The Ferring USA Product Line


    

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various products that may be of interest to Ferring's employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring.

Non-US visitors, please visit our international site at www.ferring.com.

©2008-2010 Ferring Pharmaceuticals